Correlation Between Spyre Therapeutics and 718172CZ0

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 718172CZ0 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 718172CZ0 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and PM 4875 15 FEB 28, you can compare the effects of market volatilities on Spyre Therapeutics and 718172CZ0 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 718172CZ0. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 718172CZ0.

Diversification Opportunities for Spyre Therapeutics and 718172CZ0

0.12

Correlation Coefficient

Spyre Therapeutics  718172CZ0

Average diversification

The 3 months correlation between Spyre and 718172CZ0 is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and PM 4875 15 FEB 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PM 4875 15 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 718172CZ0. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PM 4875 15 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 718172CZ0 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 718172CZ0

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the 718172CZ0. In addition to that, Spyre Therapeutics is 11.04 times more volatile than PM 4875 15 FEB 28. It trades about -0.03 of its total potential returns per unit of risk. PM 4875 15 FEB 28 is currently generating about -0.08 per unit of volatility. If you would invest  10,145  in PM 4875 15 FEB 28 on October 7, 2024 and sell it today you would lose (173.00) from holding PM 4875 15 FEB 28 or give up 1.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  PM 4875 15 FEB 28

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

PM 4875 15

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PM 4875 15 FEB 28 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 718172CZ0 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Spyre Therapeutics and 718172CZ0

The main advantage of trading using opposite Spyre Therapeutics and 718172CZ0 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 718172CZ0 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 718172CZ0 will offset losses from the drop in 718172CZ0's long position.

The idea behind Spyre Therapeutics and PM 4875 15 FEB 28 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.